• 1
    de Jong, M. A. and Geijtenbeek, T. B., Langerhans cells in innate defense against pathogens. Trends. Immunol. 2010. 31: 452459.
  • 2
    Romani, N., Flacher, V., Tripp, C. H., Sparber, F., Ebner, S. and Stoitzner, P., Targeting skin dendritic cells to improve intradermal vaccination. Curr. Top. Microbiol. Immunol. 2012. 351: 113138.
  • 3
    de Witte, L., Nabatov, A., Pion, M., Fluitsma, D., de Jong, M. A., de Gruijl, T., Piguet, V. et al., Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007. 13: 367371.
  • 4
    de Jong, M. A., Vriend, L. E., Theelen, B., Taylor, M. E., Fluitsma, D., Boekhout, T. and Geijtenbeek, T. B., C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol. Immunol. 2010. 47: 12161225.
  • 5
    Geijtenbeek, T. B. and Gringhuis, S. I., Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009. 9: 465479.
  • 6
    Takeuchi, J., Watari, E., Shinya, E., Norose, Y., Matsumoto, M., Seya, T., Sugita, M. et al., Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 2003. 306: 674679.
  • 7
    van der Aar, A. M., Sylva-Steenland, R. M., Bos, J. D., Kapsenberg, M. L., de Jong, E. C. and Teunissen, M. B., Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 2007. 178: 19861990.
  • 8
    Igyarto, B. Z., Haley, K., Ortner, D., Bobr, A., Gerami-Nejad, M., Edelson, B. T., Zurawski, S. M. et al., Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011. 35: 260272.
  • 9
    Geissmann, F., Prost, C., Monnet, J. P., Dy, M., Brousse, N. and Hermine, O., Transforming growth factor beta-1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 1998. 187: 961966.
  • 10
    Ohtani, T., Mizuashi, M., Nakagawa, S., Sasaki, Y., Fujimura, T., Okuyama, R. and Aiba, S., TGF-beta-1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 2009. 126: 485499.
  • 11
    Tang, A., Amagai, M., Granger, L. G., Stanley, J. R. and Udey, M. C., Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993. 361: 8285.
  • 12
    Blauvelt, A., Katz, S. I. and Udey, M. C., Human Langerhans cells express E-cadherin. J. Invest. Dermatol. 1995. 104: 293296.
  • 13
    Chorro, L., Sarde, A., Li, M., Woollard, K. J., Chambon, P., Malissen, B., Kissenpfennig, A. et al., Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 2009. 206: 30893100.
  • 14
    Renn, C. N., Sanchez, D. J., Ochoa, M. T., Legaspi, A. J., Oh, C. K., Liu, P. T., Krutzik, S. R. et al., TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J. Immunol. 2006. 177: 298305.
  • 15
    Van den Bossche, J., Malissen, B., Mantovani, A., De Baetselier, P. and Van Ginderachter, J. A., Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. Blood 2012. 119: 16231633.
  • 16
    Strobl, H., Riedl, E., Scheinecker, C., Bello-Fernandez, C., Pickl, W. F., Rappersberger, K., Majdic, O. et al., TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 1996. 157: 14991507.
  • 17
    Soulas, C., Arrighi, J. F., Saeland, S., Chapuis, B. and Kindler, V., Human CD34+ CD11b-cord blood stem cells generate in vitro a CD34- CD11b+ subset that is enriched in langerin+ Langerhans dendritic cell precursors. Exp. Hematol. 2006. 34: 14711479.
  • 18
    Riedl, E., Stockl, J., Majdic, O., Scheinecker, C., Knapp, W. and Strobl, H., Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 2000. 96: 42764284.
  • 19
    Gottardi, C. J., Wong, E. and Gumbiner, B. M., E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell. Biol. 2001. 153: 10491060.
  • 20
    Takahashi, H., Nakagawa, Y., Leggatt, G. R., Ishida, Y., Saito, T., Yokomuro, K. and Berzofsky, J. A., Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism? J. Exp. Med. 1996. 183: 879889.
  • 21
    Nagaoka, M., Si-Tayeb, K., Akaike, T. and Duncan, S. A., Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev. Biol. 2010. 10: 60.
  • 22
    Yagi, Y., Watanabe, E., Watari, E., Shinya, E., Satomi, M., Takeshita, T. and Takahashi, H., Inhibition of DC-SIGN-mediated transmission of human immunodeficiency virus type 1 by Toll-like receptor 3 signalling in breast milk macrophages. Immunology 2010. 130: 597607.